Health and quality of life of patients with haemophilia: A national study of 124 Danish men

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 210 KB, PDF-dokument

Purpose
In the past decades, haemophilia treatment has greatly improved the health of persons with haemophilia (PWH). This study compares PWH to the general population on social conditions and health.

Methods
In December 2021, all Danes with moderate or severe haemophilia A or B, or von Willebrands disease type 3 were invited to participate in an online self-report survey concerning sociodemographic factors, self-rated health, teeth status, chronic health conditions, symptoms and loneliness. This study compares responses from the 124 adult male PWH with responses from a male general population sample (N = 4849). Analyses used logistic regression, controlling for age and highest completed education.

Results
Fewer PWH were in the oldest age group (65-84 years). Controlling for age, no significant differences were found regarding cohabitation status or education. Fewer PWH were employed (OR = .48, [.33-.71])—particularly in the 45–64 age group. PWH were less likely to report good health (OR = .49, [.31-.77]). The odds of joint disease was much higher (OR = 13.00, [8.37-20.28]). Also, hypertension (OR = 2.25, [1.13-5.65]) and previous stroke (OR = 2.51, [1.44-3.50]) were more frequent. PWH were more likely to report pain in the arms/hands/legs/hips (OR = 2.94, [1.92-4.52]), but less likely to report pain in the head/neck/shoulder (OR = .66, [.45-.96]).

Conclusion
The disease burden of haemophilia has improved so PWH resembles the general population in areas such as marriage and education. However, even for young PWH, the disease still imposes a significant burden from hemophilia arthropathy and pain in extremities and joints. Middle-aged PWH also have poorer levels of employment than same-aged peers.
OriginalsprogEngelsk
BogserieHaemophilia
Vol/bind29
Udgave nummer2
Sider (fra-til)538-544
Antal sider7
ISSN1351-8216
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
Eva Funding reports speakers fee from BMS and travel grant from AOP orphan pharmaceuticals. All other authors declare no conflict of interest.

Publisher Copyright:
© 2023 The Authors. Haemophilia published by John Wiley & Sons Ltd.

ID: 336290932